Phio pharmaceuticals fintel
WebbPhio Pharmaceuticals Corp (NASDAQ:PHIO) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in … Webb8 apr. 2024 · MARLBOROUGH, Mass., April 8, 2024 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO ), a clinical stage biotechnology company developing the next generation of therapeutics based on...
Phio pharmaceuticals fintel
Did you know?
Webb22 feb. 2024 · Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology is designed to make immune cells more effective in killing tumor cells. Corporate Presentation The following is an investor update, effective January 2024, presented by Robert Bitterman. Mr. WebbPHIO Institutional Ownership, Sellers - Phio Pharmaceuticals Corp. Fintel ...
WebbPhio Pharmaceuticals Corp (PHIO) Stock Price Today, News, Quotes, FAQs and Fundamentals 8.50% KRYS 4.70% INFY 0.46% FAST 0.66% UNL 3.55% More … WebbPHIO - Phio Pharmaceuticals Corp. Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Monthly Draw Fullscreen Settings PHIO - Stock Price Chart PHIO [NASD]
WebbPHIO / Phio Pharmaceuticals Corp - Net Long/Short Value This page provides the net long/short valuations for each institutional holding reported via 13F or NPORT filings. To … Webb2024-11-14 - BlackRock Inc. has filed a 13F-HR form disclosing ownership of 19 shares of Phio Pharmaceuticals Corp (US:PHIO) with total holdings valued at $0 USD as of 2024 …
WebbPhio Pharmaceuticals Contact Us Contact Us Get in touch with us. General inquiries: [email protected] Investor relations information: [email protected] …
WebbPhio Pharmaceuticals stock is traded on Nasdaq as PHIO. The firm is headquartered in Marlborough, Ma. in Middlesex County. The firm's Chairman is Robert Bitterman, … pararadiatoriWebb30 mars 2024 · Phio Pharmaceuticals - PHIO News Today $5.99 +0.16 (+2.74%) (As of 03/30/2024 10:41 AM ET) Compare Today's Range $5.75 $5.99 50-Day Range $0.51 $6.85 52-Week Range $3.90 $29.04 Volume 1,039 shs Average Volume 36,447 shs Market Capitalization $6.89 million P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile … para que sirve vitamina d3 1000WebbPhio Pharmaceuticals Corp. 257 Simarano Drive, Suite 101 Marlborough, MA 01752 (508) 767-3861 February 7, 2024 VIA EDGAR Securities and Exchange Commission Division of … オデッセイ リアモニター 配線WebbPhio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL™ RNAi technology makes immune cells more effective in … オデッセイ リアバンパー外し 方WebbThe average one-year price target for Phio Pharmaceuticals is $73.44 The forecasts range from a low of $72.72 to a high of $75.60. Update Frequency: Monthly PHIO / Phio … オデッセイ ランプ 意味para que sirvio la etapa neoliticaWebbResumen PHIO Gráfico técnico Phio Pharmaceuticals Corp 5,527 + 0,259 ( + 4,92 %) S 1 semana 1 año Máx. Último cierre 5,268 Rango día 5,321 - 6 Ingresos - Apertura 5,321 52 semanas 3,9 - 29,04... オデッセイ ロードバイク 積載